Mirae Asset Global ETFs Holdings

Mirae Asset Global ETFs Holdings’s Relay Therapeutics RLAY Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio RLAY Stock Details RLAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$756K	Sell	76,661 -18	-0%	-$161	﹤0.01%	1658
2025 Q4	$647K	Buy	76,679 +6,650	+9%	+$47.5K	﹤0.01%	1761
2025 Q3	$365K	Sell	70,029 -12,334	-15%	-$47K	﹤0.01%	2022
2025 Q2	$283K	Sell	82,363 -1,706	-2%	-$5.07K	﹤0.01%	2095
2025 Q1	$221K	Buy	84,069 +5,238	+7%	+$20.5K	﹤0.01%	2274
2024 Q4	$325K	Buy	78,831 +17,009	+28%	+$92.6K	﹤0.01%	2124
2024 Q3	$440K	Buy	61,822 +5,711	+10%	+$42.7K	﹤0.01%	1977
2024 Q2	$364K	Buy	+56,111	New	+$383K	﹤0.01%	1967

Other funds holding RLAY

SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return